Astrazeneca plc
NASDAQ: AZN
$63.86
-$2.41 (-3.6%)
Closing Price on November 6, 2024
AZN Articles
Several big FDA decisions should be coming up in the June quarter for the likes of AstraZeneca and Sarepta Therapeutics.
Published:
Last Updated:
A pharmaceutical company could face a threat to one of its products for a number of reasons, ranging from an improved formulation to a patent expiry and the opening of the floodgates for generic...
Published:
Last Updated:
Attaining a certain drug can mean the difference between life and death for millions of Americans. These essential products also help generate billions for drug manufacturers. Pharmaceutical...
Published:
Last Updated:
Inovio Pharmaceuticals made waves early on Tuesday morning following an update for its human papillomavirus (HPV) treatment.
Published:
Last Updated:
March 22, 2016: Here are four stocks trading with relatively heavy volume among 21 equities making new 52-week lows in Tuesday’s session. AstraZeneca PLC (NYSE: AZN) dropped about 2.5% on Tuesday...
Published:
Last Updated:
Tuesday's top analyst initiations, upgrades and downgrades include AstraZeneca, 3D Systems, Barrick Gold, Home Depot, Oasis Petroleum and Whiting Petroleum.
Published:
Last Updated:
AstraZeneca has announced that the European Commission granted marketing authorization for two of its treatments: Zurampic for gout and Brilique for heart attack patients.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Monday, February 8 include Athenahealth, Baker Hughes, Cisco, LinkedIn, Orbital-ATK and Tableau Software.
Published:
Last Updated:
Stocks tanked on Friday but were indicated sharply higher on Tuesday after the three-day weekend and after China’s gross domestic product met expectations. While investors may feel that every rally...
Published:
Last Updated:
Good news for those who suffer from high levels of uric acid and from gout: the FDA has approved a new gout treatment.
Published:
Last Updated:
Jefferies has updated the thesis behind its "Top 5 for 2015" pharmaceutical stock picks
Published:
Last Updated:
Wednesday's top analyst upgrades, downgrades and initiations include Aegerion Pharmaceuticals, Amazon.com, EMC, McDonald's, MetLife, Microsoft, SanDisk and Tyco International.
Published:
Last Updated:
Tuesday's top analyst upgrades, downgrades and initiations include Bluebird Bio, Boston Beer, Etsy, Gilead Sciences, Pfizer, PMC-Sierra and Valeant Pharmaceuticals.
Published:
Last Updated:
Monday's top analyst upgrades, downgrades and initiations include AeroVironment, Gold Fields, Marvell Technology, Nokia and Silver Wheaton.
Published:
Wednesday’s top analyst upgrades, downgrades and initiations include ARM Holdings, AT&T, Hasbro, Lending Club, PNC Financial Services, Vodafone and Walt Disney.
Published: